羟基磷灰石义眼座眶内植入二十年回顾  

Twenty years review of the hydroxyapatite orbital implant

作　　者：宋斗[1] 尤媛[1] 高丽雅 陈杰[1] Song Dou;You Yuan;Gao Liya;Chen Jie(Department of Ophthalmology, The 903th Hospital of Chinese PLA, Hangzhou 310013, China)

机构地区：[1]解放军第903医院眼科(原解放军第117医院),杭州310013

出　　处：《中华眼外伤职业眼病杂志》2019年第7期536-538,共3页Chinese Journal of Ocular Trauma and Occupational Eye Disease

摘　　要：目的评价眼球摘出后羟基磷灰石义眼座眶内植入的远期疗效。方法对我院二十年来羟基磷灰石义眼座眶内植入613例临床资料进行回顾性分析。结果经过1~20年的随访,613例中义眼座暴露8例,义眼座排异2例,结膜囊狭窄31例,轻度上睑下垂18例,上睑沟凹陷57例,下睑松弛43例,下穹隆变浅33例,结膜肉芽组织增生19例。无术后继发感染病例。结论羟基磷灰石眼座眶内植入经较长期的随访,并发症少且较轻微,外观满意。Objective To evaluate the long-term efficacy of hydroxyapatite orbital implant after eyeball enucleation. Methods The data of 613 eyes of 613 patients which received hydroxyapatite orbital implant from Oct.1996 to Sep.2016 were analyzed retrospectively. The followed-up time was 1-20 years. Results There were artificial orbital implant exposure in 8 patients, hydroxyapatite extrusion in 2 cases, conjunctival sac constriction in 31 cases, mild degree ptosis in 18 cases, sunken eye lid in 57 cases, loose lower lid in 43 cases, shallow lower fornix in 33 cases and conjunctival granulation tissue hyperplasia in 19 cases. No secondary infection occurred postoperatively. Conclusion The hydroxyapatite orbital implant is an effective treatment, with a low rate, mild complications and satisfactory appearance.

关 键 词：义眼座 羟基磷灰石 植入 眼眶 

分 类 号：R779.64[医药卫生—眼科]